Page 22 - Use Authorization News Today

U.S. health advisers are urging a booster dose of Pfizer's COVID-19 vaccine for kids ages 5 to 11.

Vaccine advisers to the US Centers for Disease Control and Prevention voted 11-1, with 1 abstention Thursday to support recommending a booster dose of the Pfizer/BioNTech Covid-19 vaccine for 5-

Beginning Friday, May 20, Texas Children’s Hospital and all Texas Children’s Pediatrics practices will begin administering the Pfizer-BioNTech COVID-19 vaccine booster to children aged 5 to 11, following FDA Emergency-Use Authorization granted May 17, and recommendation today by the CDC Advisory Committee on Immunization Practices.

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

An overall market rebound and Tuesday's authorization of boosters for kids likely propelled the stock higher.

U.S. health advisers are urging a booster dose of Pfizer's COVID-19 vaccine for kids ages 5 to 11.

The U.S. Food and Drug Administration (FDA) has given approval for the commercialization of Eli Lilly and Company and Incyte’s Olumiant (baricitinib), setting a precedent for COVID-19 treatments.

The vaccine maker faces a few big uncertainties.

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Q1 2022 total revenue was $8.7 million, including product sales of $7.9 million.  Core non-COVID-19 product sales were an estimated $7.6 million, ...